Qinlock and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Qinlock (ripretinib) and Oxycodone (oxycodone hydrochloride). Common drug interactions include dry skin among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Qinlock and Oxycodone. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Qinlock?

Qinlock has active ingredients of ripretinib. eHealthMe is studying from 3,803 Qinlock users. Check the latest studies of Qinlock.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,588 Oxycodone users. Check the latest studies of Oxycodone.

On Dec, 19, 2025

37 people who take Qinlock and Oxycodone together, and have interactions are studied.

Qinlock and Oxycodone drug interactions.

What are the common drug interactions of Qinlock and Oxycodone, by gender? *:

female:

Dry skin
Dyspnoea (difficult or laboured respiration)
Hepatic enzyme increased
Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Productive cough
Rash
Red blood cell count decreased
Skin exfoliation (removal of the oldest dead skin cells)

male:

Fatigue (feeling of tiredness)
Constipation
Pruritus (severe itching of the skin)
Weight decreased
Appetite disorder (abnormal eating habits)
Blood glucose decreased
Decreased appetite
Dry skin
Insomnia (sleeplessness)
Joint swelling

What are the common drug interactions of Qinlock and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Hepatic enzyme increased

20-29:

n/a

30-39:

Dry skin
Dyspnoea (difficult or laboured respiration)
Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Productive cough
Skin exfoliation (removal of the oldest dead skin cells)

40-49:

n/a

50-59:

Fatigue (feeling of tiredness)
Abdominal pain
Anaemia (lack of blood)
Anxiety
Arthralgia (joint pain)
Bone pain
Cellulitis (infection under the skin)
Constipation
Dizziness
Dry skin

60+:

Nausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)
Alopecia (absence of hair from areas of the body)
Constipation
Neoplasm progression (growth of tumour)
Abdominal pain
Arthralgia (joint pain)
Decreased appetite
Fall
Headache (pain in head)

What are the existing conditions these people have? *

Gastrointestinal Stromal Tumor: 18 people, 48.65%
Nausea And Vomiting: 2 people, 5.41%
Nausea (feeling of having an urge to vomit): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Qinlock and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously